Screener
Viridian Therapeutics, Inc. VRDN Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 2,765 | 1,228 |
| Operating lease right-of-use asset | 2,085 | 2,421 |
| Intangible asset, net | 10,000 | — |
| Other assets | 1,113 | 1,536 |
| Total assets | $1,097,233 | $899,418 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $8,652 | $8,683 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s other non-current assets?
- Viridian Therapeutics, Inc. (VRDN) reported other non-current assets of $1.11M in Q2 2026.
- How has Viridian Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Viridian Therapeutics, Inc.'s other non-current assets increased by 120.0% year-over-year, from $506K to $1.11M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s other non-current assets has grown at a 333.8% compound annual growth rate (CAGR), from $1K to $1.54M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Viridian Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude